#1 Clinical Trials Search in Europe

Candesartan Cilexetil

Candesartan Cilexetil, also known by the brand name Atacand, is an angiotensin receptor blocker (ARB) that has been extensively studied in clinical trials for various conditions, primarily hypertension and kidney-related disorders. This article summarizes key findings from clinical trials investigating the use of Candesartan Cilexetil, providing insights into its effectiveness, safety profile, and potential applications in different patient populations.

Table of Contents

What is Candesartan Cilexetil?

Candesartan Cilexetil is a medication used to treat various cardiovascular conditions. It is known by several brand names, including Atacand, Blopress, and Atacand PROTECT[1][2]. This drug belongs to a class of medications called angiotensin receptor blockers (ARBs), which work by relaxing blood vessels to lower blood pressure and improve heart function[1].

Medical Uses

Candesartan Cilexetil is primarily used to treat the following conditions:

  • Hypertension (High Blood Pressure): It is effective in lowering blood pressure in adults and children[3][4].
  • Heart Failure: It can be used to treat heart failure in adults[2].
  • Diabetic Nephropathy: It may help protect the kidneys in patients with type 1 diabetes[5].
  • Diabetic Retinopathy: Studies have investigated its potential in preventing or slowing the progression of eye problems in diabetic patients[6].

How Candesartan Cilexetil Works

Candesartan Cilexetil is a prodrug, which means it is inactive when taken and becomes active in the body. Once ingested, it is converted to its active form, candesartan[7]. Candesartan works by blocking the action of a hormone called angiotensin II. This hormone causes blood vessels to narrow, which can increase blood pressure. By blocking this hormone, Candesartan allows blood vessels to relax and widen, lowering blood pressure and reducing strain on the heart[1].

Dosage Forms and Administration

Candesartan Cilexetil is available in several forms:

  • Tablets: Common strengths include 4 mg, 8 mg, 16 mg, and 32 mg[1][7].
  • Oral Suspension: A liquid form is available for patients who have difficulty swallowing tablets, particularly children[8].

The dosage depends on the condition being treated, the patient’s age, and other factors. For adults with hypertension, the usual starting dose is 4 to 8 mg once daily, which can be increased up to 32 mg if needed[1]. For patients with kidney problems, treatment usually starts at a lower dose of 2 mg once daily[2].

Clinical Studies and Effectiveness

Numerous clinical trials have been conducted to evaluate the effectiveness of Candesartan Cilexetil:

  • Hypertension: Studies have shown that Candesartan effectively lowers both systolic and diastolic blood pressure in adults and children[3][4].
  • Diabetic Nephropathy: Research has indicated that Candesartan may help reduce protein excretion in urine, a sign of kidney damage in diabetic patients[5].
  • Diabetic Retinopathy: A large-scale study called DIRECT investigated whether Candesartan could prevent or slow the progression of retinopathy in type 1 diabetic patients[6].

Side Effects and Safety

Like all medications, Candesartan Cilexetil can cause side effects. Common side effects may include:

  • Dizziness
  • Headache
  • Back pain
  • Respiratory infections

More serious side effects, though rare, can include severe allergic reactions, kidney problems, or high potassium levels in the blood. It’s important to discuss any side effects with your healthcare provider[7].

Use in Special Populations

Children: Candesartan has been studied in children as young as 1 year old for the treatment of hypertension. The dosage for children is typically based on weight[4].

Pregnant Women: Candesartan is not recommended during pregnancy as it can harm the developing fetus, especially in the second and third trimesters.

Elderly Patients: Older adults may be more sensitive to the effects of Candesartan and may require lower starting doses[2].

Patients with Kidney or Liver Problems: Lower starting doses are typically recommended for these patients, and close monitoring may be necessary[2].

Aspect Details
Primary Uses Hypertension, Non-diabetic Nephropathy, Diabetic Retinopathy
Dosage Range 2 mg to 32 mg daily
Administration Oral tablets or suspension
Key Outcomes Measured Blood pressure reduction, Urinary protein/creatinine ratio, Retinopathy progression
Safety Profile Generally well-tolerated; common side effects include dizziness and headache
Special Populations Studied Pediatric patients, Patients with kidney disease, Diabetic patients
Trial Durations Range from several weeks to 5 years
Combination Therapies Studied with hydrochlorothiazide, amlodipine

FAQ

  • What is Candesartan Cilexetil used for? Candesartan Cilexetil is primarily used to treat hypertension (high blood pressure). It has also been studied for its potential benefits in kidney disorders, diabetic retinopathy, and other cardiovascular conditions.
  • How does Candesartan Cilexetil work? Candesartan Cilexetil is an angiotensin receptor blocker (ARB). It works by blocking the action of a hormone called angiotensin II, which causes blood vessels to narrow. By blocking this hormone, Candesartan helps blood vessels relax and widen, lowering blood pressure.
  • What dosages of Candesartan Cilexetil have been studied in clinical trials? Clinical trials have investigated various dosages of Candesartan Cilexetil, ranging from 2 mg to 32 mg daily. The specific dosage depends on the condition being treated and individual patient factors.
  • Are there any side effects associated with Candesartan Cilexetil? Like all medications, Candesartan Cilexetil can cause side effects. Common side effects may include dizziness, headache, and upper respiratory tract infections. However, the specific side effects and their frequency can vary depending on the dosage and individual patient characteristics.
  • How long do clinical trials for Candesartan Cilexetil typically last? The duration of clinical trials for Candesartan Cilexetil varies widely depending on the study objectives. Some trials last for a few weeks, while others can extend up to several years. For example, one study investigating its effects on diabetic retinopathy lasted for 5 years.

Ongoing Clinical Trials on Candesartan Cilexetil

  • Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands Spain

Glossary

  • Angiotensin Receptor Blocker (ARB): A class of medication that blocks the action of angiotensin II, a hormone that narrows blood vessels. ARBs are commonly used to treat high blood pressure and heart failure.
  • Hypertension: A medical condition characterized by persistently elevated blood pressure in the arteries. It is also commonly known as high blood pressure.
  • Nephropathy: A general term for kidney disease or damage. In the context of diabetes, it refers to kidney damage resulting from long-term diabetes.
  • Diabetic Retinopathy: A complication of diabetes that affects the eyes. It occurs when high blood sugar levels damage the blood vessels in the retina, potentially leading to vision problems or blindness.
  • Bioequivalence: A term used in pharmacology to describe when two drugs with the same active ingredient have essentially the same bioavailability and effects in the body.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Cmax: The maximum concentration of a drug observed in the blood plasma after administration.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, used in pharmacokinetic studies to assess drug absorption and elimination.
  • Urinary Albumin Excretion Rate (UAER): The amount of albumin (a protein) excreted in the urine over a specific time period. Elevated levels can indicate kidney damage.
  • Systolic Blood Pressure (SBP): The pressure in the arteries when the heart beats (contracts). It is the higher number in a blood pressure reading.
  • Diastolic Blood Pressure (DBP): The pressure in the arteries when the heart is at rest between beats. It is the lower number in a blood pressure reading.

References

  1. https://clinicaltrials.gov/study/NCT02211638
  2. https://clinicaltrials.gov/study/NCT02166697
  3. https://clinicaltrials.gov/study/NCT00621153
  4. https://clinicaltrials.gov/study/NCT00244621
  5. https://clinicaltrials.gov/study/NCT00573430
  6. https://clinicaltrials.gov/study/NCT00252733
  7. https://clinicaltrials.gov/study/NCT04012307
  8. https://clinicaltrials.gov/study/NCT00844324